Wayne Clark
Nurse Practitioner · Yakima, WANPI 1568479400
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Medtronic at 46.2% of the total. Reporting peaked in 2022 at $291 and has fallen 90.5% since, to $28 in 2025.
Across 15 payments — averaging $41.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$289
- Nevro Corp.$152
- Avanos Medical$69
- Abiomed$63
- Boston Scientific$53
Across 25 payments — averaging $9269.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$232K
What the payments were for
- Food & beverage$625100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 7 | $289 |
| Nevro Corp. | 4 | $152 |
| Avanos Medical | 1 | $69 |
| Abiomed | 1 | $63 |
| Boston Scientific | 2 | $53 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$625 in reported general payments places this provider in the 85th percentile of 2,466 nurse practitioner providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $9,007 |
| Buprenorphine | 36 | $8,690 |
| Chlorzoxazone | 25 | $8,405 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 176 | $6,175 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 177 | $5,409 |
| Lidocaine | 43 | $4,159 |
| Fentanyl | 48 | $4,103 |
| Oxycodone Hcl | 158 | $4,005 |
| Gabapentin | 168 | $3,995 |
| Morphine Sulfate ErMorphine Sulfate | 133 | $3,335 |
| Celecoxib | 37 | $2,811 |
| Morphine Sulfate | 43 | $2,121 |
| Pregabalin | 117 | $2,027 |
| Hydromorphone Hcl | 90 | $1,779 |
| Diclofenac Sodium | 38 | $1,596 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Yakima
- Bonnie KultgenYakima$11K
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Felicia ForrestLynnwood$206K
- Amaris MurphyBellevue$146K
- Sonia GlennieSeattle$78K
- Megan WildesTacoma$72K
- Kate KennedyBellevue$63K
- Vicki HainesPasco$57K
- Jessica ArmitageSumner$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.